Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126236811 | 12623681 | 1 | I | 20130924 | 20160804 | 20160804 | PER | US-JAZZ-2013-US-001393 | JAZZ | 0.00 | F | Y | 0.00000 | 20160804 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126236811 | 12623681 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | A22838 | 21196 | 3 | G | ORAL SOLUTION | ||||||
| 126236811 | 12623681 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4 G, BID | A19535 | 21196 | 4 | G | ORAL SOLUTION | ||||||
| 126236811 | 12623681 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | A24529 | 21196 | 4.5 | G | ORAL SOLUTION | ||||||
| 126236811 | 12623681 | 4 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4 G, BID | 3097762 | 21196 | 4 | G | ORAL SOLUTION | ||||||
| 126236811 | 12623681 | 5 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | 3101985 | 21196 | 4.5 | G | ORAL SOLUTION | ||||||
| 126236811 | 12623681 | 6 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4 G, BID | 21196 | 4 | G | ORAL SOLUTION | |||||||
| 126236811 | 12623681 | 7 | SS | Antihypertensives | UNSPECIFIED INGREDIENT | 1 | UNK | 0 | |||||||||||
| 126236811 | 12623681 | 8 | SS | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 126236811 | 12623681 | 9 | C | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | UNK | U | 0 | ||||||||||
| 126236811 | 12623681 | 10 | C | KLONOPIN | CLONAZEPAM | 1 | UNK | U | 0 | ||||||||||
| 126236811 | 12623681 | 11 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | Oral | UNK | U | 0 | |||||||||
| 126236811 | 12623681 | 12 | C | LIDOCAINE. | LIDOCAINE | 1 | UNK | U | 0 | ||||||||||
| 126236811 | 12623681 | 13 | C | ASPIRIN. | ASPIRIN | 1 | Oral | UNK, PRN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126236811 | 12623681 | 1 | Narcolepsy |
| 126236811 | 12623681 | 7 | Hypertension |
| 126236811 | 12623681 | 8 | Thyroid disorder |
| 126236811 | 12623681 | 9 | Product used for unknown indication |
| 126236811 | 12623681 | 10 | Product used for unknown indication |
| 126236811 | 12623681 | 11 | Product used for unknown indication |
| 126236811 | 12623681 | 12 | Pain |
| 126236811 | 12623681 | 13 | Pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126236811 | 12623681 | Anxiety | |
| 126236811 | 12623681 | Body temperature increased | |
| 126236811 | 12623681 | Dysstasia | |
| 126236811 | 12623681 | Feeling hot | |
| 126236811 | 12623681 | Hypothyroidism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126236811 | 12623681 | 1 | 200702 | 2007 | 0 | |
| 126236811 | 12623681 | 2 | 200704 | 2007 | 0 | |
| 126236811 | 12623681 | 3 | 200706 | 2012 | 0 | |
| 126236811 | 12623681 | 4 | 201207 | 2013 | 0 | |
| 126236811 | 12623681 | 5 | 201302 | 2016 | 0 | |
| 126236811 | 12623681 | 6 | 201602 | 0 |